| Ascentage Pharma Group International (NASDAQ:AAPG) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $31.79. |
| Airbnb (NASDAQ:ABNB) is now covered by analysts at BNP Paribas Exane. They set a "neutral" rating on the stock.The current price is $113.62. |
| Abivax (NASDAQ:ABVX) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $122.55. |
| Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $26.19. |
| Amazon.com (NASDAQ:AMZN) is now covered by analysts at BNP Paribas Exane. They set an "outperform" rating on the stock.The current price is $226.02. |
| Bicycle Therapeutics (NASDAQ:BCYC) is now covered by analysts at Truist Financial Corporation. They set a "hold" rating and a $19.00 price target on the stock. This represents a 190.5% upside from the current price of $6.54. |
| Booking (NASDAQ:BKNG) is now covered by analysts at BNP Paribas Exane. They set an "outperform" rating and a $6,100.00 price target on the stock. This represents a 25.6% upside from the current price of $4,855.47. |
| CG Oncology (NASDAQ:CGON) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $43.70. |
| eBay (NASDAQ:EBAY) is now covered by analysts at BNP Paribas Exane. They set a "neutral" rating on the stock.The current price is $80.54. |
| Etsy (NASDAQ:ETSY) is now covered by analysts at BNP Paribas Exane. They set a "neutral" rating on the stock.The current price is $51.95. |
| Expedia Group (NASDAQ:EXPE) is now covered by analysts at BNP Paribas Exane. They set a "neutral" rating on the stock.The current price is $249.37. |
| Fulcrum Therapeutics (NASDAQ:FULC) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $11.77. |
| Alphabet (NASDAQ:GOOGL) is now covered by analysts at BNP Paribas Exane. They set an "outperform" rating and a $355.00 price target on the stock. This represents a 11.9% upside from the current price of $317.39. |
| Granite Construction (NYSE:GVA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $109.00 price target on the stock. This represents a 3.7% upside from the current price of $105.06. |
| Hyatt Hotels (NYSE:H) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $178.00 price target on the stock. This represents a 11.4% upside from the current price of $159.84. |
| IDEAYA Biosciences (NASDAQ:IDYA) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $34.93. |
| Jacobs Solutions (NYSE:J) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $158.00 price target on the stock. This represents a 17.4% upside from the current price of $134.60. |
| Meta Platforms (NASDAQ:META) is now covered by analysts at BNP Paribas Exane. They set an "outperform" rating and a $800.00 price target on the stock. This represents a 30.5% upside from the current price of $613.06. |
| MannKind (NASDAQ:MNKD) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $5.13. |
| Navan (NASDAQ:NAVN) is now covered by analysts at Citizens Jmp. They set a "market outperform" rating and a $25.00 price target on the stock. This represents a 65.6% upside from the current price of $15.10. |
| Navan (NASDAQ:NAVN) is now covered by analysts at Mizuho. They set an "outperform" rating and a $25.00 price target on the stock. This represents a 65.6% upside from the current price of $15.10. |
| Navan (NASDAQ:NAVN) is now covered by analysts at BNP Paribas Exane. They set an "outperform" rating and a $24.00 price target on the stock. This represents a 58.9% upside from the current price of $15.10. |
| Navan (NASDAQ:NAVN) is now covered by analysts at Rosenblatt Securities. They set a "buy" rating and a $30.00 price target on the stock. This represents a 98.7% upside from the current price of $15.10. |
| Nuvation Bio (NYSE:NUVB) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $7.26. |
| Nuvalent (NASDAQ:NUVL) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $110.89. |
| BeOne Medicines (NASDAQ:ONC) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $352.85. |
| Primoris Services (NASDAQ:PRIM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $117.00 price target on the stock. This represents a 3.7% downside from the current price of $121.51. |
| Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $255.00 price target on the stock. This represents a 66.7% downside from the current price of $765.63. |
| Shopify (NASDAQ:SHOP) (TSE:SHOP) is now covered by analysts at BNP Paribas Exane. They set a "neutral" rating on the stock.The current price is $151.10. |
| Voyager Technologies (NYSE:VOYG) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $43.00 price target on the stock. This represents a 109.4% upside from the current price of $20.53. |
| Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $32.00. |
| Waste Management (NYSE:WM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $256.00 price target on the stock. This represents a 19.6% upside from the current price of $214.14. |
| Xencor (NASDAQ:XNCR) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.The current price is $16.81. |